Top Qs
Timeline
Chat
Perspective
Lenvervimab
Monoclonal antibody From Wikipedia, the free encyclopedia
Remove ads
Lenvervimab (INN;[1] development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B.[2]
This drug is being developed by GC Pharma. As of 2018[update], lenvervimab is undergoing Phase II/III trials.
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads